Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
From their RNS March 2nd 2022.
Physiomics will be supporting Ankyra with modelling and simulation of ANK-101 in immune-oncology settings in support of its early development.
https://www.physiomics.co.uk/contract-award-9/
Pyc reposted this about a licensing deal between Ankyra and Jenga Bioscience with their platform JEN-101 (formerly cANK-101 (PYC helped developed.)).
https://www.linkedin.com/posts/ankyratx_ankyra-therapeutics-and-jenga-biosciences-activity-7178508921270079488-WtE0?utm_source=share&utm_medium=member_desktop
Interesting.
Dose me posted on twitter on 18th March, Pyc retweeted mentioning they still working with Doseme. I’m awaiting outcome of this.
https://x.com/Physiomics/status/1772939227359007009?s=20
https://x.com/Physiomics/status/1772939225266065552?s=20
Looks like not much interest if they have to put a tweet out at 11:45 informing their presence there.
https://x.com/physiomics/status/1767879752117797059?s=61&t=0G9XeE3tHfuoBf1VEsPycQ
If unable to open previous link.
https://www.physiomics.co.uk/about/careers/
Dr Hitesh Mistry is currently named in that position, has he finally parted ways with Physiomics?
Doesn’t seem much confidence with a positive result tomorrow.
Meanwhile, new post being advertised “Principle Consultant”.
https://uk.linkedin.com/jobs/view/principal-consultant-head-of-modelling-at-physiomics-plc-3848190072
Strange, not sure if PYC has did this in the past when Interims posted.
https://x.com/InvestorMeetCo/status/1763589672016449891?s=20
This week we had following low trades.
Mon 61
Tue 31
Wed 33
Thur 33
Fri. 33
Next week maybe RNS for Interims, will this have an effect on SP?
Will there be another RNS?
Posted today. What I posted on 14th Feb.
https://www.linkedin.com/posts/physiomics-plc_national-research-council-of-canada-announces-activity-7166464012954619904-yl-u?utm_source=li_share&utm_content=feedcontent&utm_medium=g_mb_web&utm_campaign=copy
Some info on 2 of the women scientists at Physiomics.
https://www.physiomics.co.uk/celebrating-international-day-of-women-and-girls-in-science-with-the-brilliant-women-at-physiomics/
About 3 pm , PYC posted on LinkedIn their collaboration with Beyond Blood therapeutics etc.
https://www.linkedin.com/posts/physiomics-plc_precisionmedicine-neutropenia-cancer-activity-7163553091907219456-kBuW?utm_source=li_share&utm_content=feedcontent&utm_medium=g_mb_web&utm_campaign=copy
About same time, there was mention of funding for Canada-UK Quantum Projects Garner National Research Council Funding.
One of the projects is with Beyond Blood, 9th project down.
Wonder if PYC will be included with this project?
Canada-UK Quantum Projects Garner National Research Council Funding
https://www.miragenews.com/canada-uk-quantum-projects-garner-national-1173886/
Down to 33 now.
Countdown to news?
No mention of Physiomics being involved.
The following article was edited by Hitesh Mistry and reviewed by Christophe Chassagnole.
This article is part of the Research Topic
FDA Project Optimus: Dose Selection in Oncology Drug Development
Pediatric oncology drug development and dosage optimization
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1235947/full
Following from PYC blog from Jan 12th.
Welcoming 3 new members to the Team!
Dr Lea Sta (applied mathematician) and Dr David Hodson (mathematical biologist) joined our technical team to support delivery of client projects and expand into new scientific areas. Strengthening our Senior Management Team, we welcomed Dr Peter Sargent as Chief Operating Officer to help drive forward the company’s business strategy.
Wonder if mention of “expanding into new scientific areas”.
https://www.physiomics.co.uk/news-update-from-physiomics-december-2023/
Recent ariticle from Dr Hitesh Mistry plus others.
https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.3165
After months of advertising the job position of PKPD modeller scientist on PYC site, yesterday, it was removed.
Merry Christmas and a Hppy and Healthy New Year.
Last end of year messages from Physiomics.
One on twitter,
2023 has been a year filled with growth, innovation & collaboration. Huge thanks to our wonderful partners, shareholders & incredible team. Looking forward to 2024 with enthusiasm!
https://x.com/Physiomics/status/1738174971531165906?s=20
Other on LinkedIn
And that’s a wrap! 🎉 2023 has been a year filled with growth, innovation and collaboration. From expanding our team to strengthening partnerships with some incredible companies united in our mission to drive advancements in #cancercare.
But none of this would be possible without the collaboration of our wonderful partners, shareholders, and incredible team. You all have been instrumental in making this possible, and we couldn't be more grateful. 🙏
As we step forward into 2024, we are excited about the many opportunities that lay ahead. Wishing everyone a Happy Christmas and a New Year filled with health and happiness
https://www.linkedin.com/posts/physiomics-plc_cancercare-pyc-2023highlights-activity-7143940401731706880-Ahe1?utm_source=li_share&utm_content=feedcontent&utm_medium=g_mb_web&utm_campaign=copy